The herpes simplex virus type 1 (HSV-1), which affects almost two‑thirds of the world's population and is generally ...

Ongoing research within the advanced-stage melanoma therapeutic space is beginning to suggest that shorter treatment periods ...

But now, the FDA has approved a groundbreaking new therapy for patients battling late-stage melanoma, offering hope when ...